516 related articles for article (PubMed ID: 30940711)
1.
Colombo AC; Rella A; Normile T; Joffe LS; Tavares PM; de S Araújo GR; Frases S; Orner EP; Farnoud AM; Fries BC; Sheridan B; Nimrichter L; Rodrigues ML; Del Poeta M
mBio; 2019 Apr; 10(2):. PubMed ID: 30940711
[No Abstract] [Full Text] [Related]
2. Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development.
Rella A; Mor V; Farnoud AM; Singh A; Shamseddine AA; Ivanova E; Carpino N; Montagna MT; Luberto C; Del Poeta M
Front Microbiol; 2015; 6():836. PubMed ID: 26322039
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with Recombinant
Specht CA; Lee CK; Huang H; Hester MM; Liu J; Luckie BA; Torres Santana MA; Mirza Z; Khoshkenar P; Abraham A; Shen ZT; Lodge JK; Akalin A; Homan J; Ostroff GR; Levitz SM
mBio; 2017 Nov; 8(6):. PubMed ID: 29184017
[TBL] [Abstract][Full Text] [Related]
4. Three Models of Vaccination Strategies Against Cryptococcosis in Immunocompromised Hosts Using Heat-Killed
Normile TG; Del Poeta M
Front Immunol; 2022; 13():868523. PubMed ID: 35615354
[TBL] [Abstract][Full Text] [Related]
5. Vaccine protection by Cryptococcus neoformans Δsgl1 is mediated by γδ T cells via TLR2 signaling.
Normile TG; Chu TH; Sheridan BS; Del Poeta M
Mucosal Immunol; 2022 Jun; 15(6):1416-1430. PubMed ID: 36229573
[TBL] [Abstract][Full Text] [Related]
6. A Heat-Killed
Wang Y; Wang K; Masso-Silva JA; Rivera A; Xue C
mBio; 2019 Nov; 10(6):. PubMed ID: 31772051
[No Abstract] [Full Text] [Related]
7. Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.
Specht CA; Lee CK; Huang H; Tipper DJ; Shen ZT; Lodge JK; Leszyk J; Ostroff GR; Levitz SM
mBio; 2015 Dec; 6(6):e01905-15. PubMed ID: 26695631
[TBL] [Abstract][Full Text] [Related]
8. Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens.
Pirofski LA
Trends Microbiol; 2001 Sep; 9(9):445-51. PubMed ID: 11553457
[TBL] [Abstract][Full Text] [Related]
9. High affinity mimotope of the polysaccharide capsule of Cryptococcus neoformans identified from an evolutionary phage peptide library.
Beenhouwer DO; May RJ; Valadon P; Scharff MD
J Immunol; 2002 Dec; 169(12):6992-9. PubMed ID: 12471134
[TBL] [Abstract][Full Text] [Related]
10. Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.
Upadhya R; Lam WC; Maybruck B; Specht CA; Levitz SM; Lodge JK
mBio; 2016 May; 7(3):. PubMed ID: 27165801
[TBL] [Abstract][Full Text] [Related]
11.
Normile TG; Rella A; Del Poeta M
Front Cell Infect Microbiol; 2021; 11():739027. PubMed ID: 34568097
[No Abstract] [Full Text] [Related]
12. Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants.
Zhai B; Wozniak KL; Masso-Silva J; Upadhyay S; Hole C; Rivera A; Wormley FL; Lin X
mBio; 2015 Oct; 6(5):e01433-15. PubMed ID: 26443458
[TBL] [Abstract][Full Text] [Related]
13. A Novel Protocol for the Isolation of Fungal Extracellular Vesicles Reveals the Participation of a Putative Scramblase in Polysaccharide Export and Capsule Construction in
Reis FCG; Borges BS; Jozefowicz LJ; Sena BAG; Garcia AWA; Medeiros LC; Martins ST; Honorato L; Schrank A; Vainstein MH; Kmetzsch L; Nimrichter L; Alves LR; Staats CC; Rodrigues ML
mSphere; 2019 Mar; 4(2):. PubMed ID: 30894430
[TBL] [Abstract][Full Text] [Related]
14. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection.
Fleuridor R; Lees A; Pirofski L
J Immunol; 2001 Jan; 166(2):1087-96. PubMed ID: 11145689
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan.
Datta K; Lees A; Pirofski LA
Clin Vaccine Immunol; 2008 Aug; 15(8):1176-87. PubMed ID: 18524882
[TBL] [Abstract][Full Text] [Related]
16. Regulated Release of Cryptococcal Polysaccharide Drives Virulence and Suppresses Immune Cell Infiltration into the Central Nervous System.
Denham ST; Verma S; Reynolds RC; Worne CL; Daugherty JM; Lane TE; Brown JCS
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29203547
[No Abstract] [Full Text] [Related]
17. Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.
Maitta RW; Datta K; Lees A; Belouski SS; Pirofski LA
Infect Immun; 2004 Jan; 72(1):196-208. PubMed ID: 14688097
[TBL] [Abstract][Full Text] [Related]
18. A Glucuronoxylomannan Epitope Exhibits Serotype-Specific Accessibility and Redistributes towards the Capsule Surface during Titanization of the Fungal Pathogen Cryptococcus neoformans.
Probert M; Zhou X; Goodall M; Johnston SA; Bielska E; Ballou ER; May RC
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670549
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to keyhole limpet hemocyanin cross-react with an epitope on the polysaccharide capsule of Cryptococcus neoformans and other carbohydrates: implications for vaccine development.
May RJ; Beenhouwer DO; Scharff MD
J Immunol; 2003 Nov; 171(9):4905-12. PubMed ID: 14568972
[TBL] [Abstract][Full Text] [Related]
20. A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan.
Albuquerque PC; Cordero RJ; Fonseca FL; Peres da Silva R; Ramos CL; Miranda KR; Casadevall A; Puccia R; Nosanchuk JD; Nimrichter L; Guimaraes AJ; Rodrigues ML
Fungal Genet Biol; 2012 Nov; 49(11):943-54. PubMed ID: 23010152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
